Cabaletta Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Cabaletta Bio, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue0.000.000.000.000.000.00
Cost of Revenue4.810.000.000.000.000.00
Gross Profit-4.810.000.000.000.000.00
Operating Expenses
Research & Development97.2055.4239.3032.4921.1111.67
Selling, General & Administrative27.9419.2414.8413.8212.727.01
Operating Expenses125.1474.6654.1446.3133.8318.68
Operating Income-125.14-74.66-54.14-46.31-33.83-18.68
Other Income/Expense
Interest Income10.036.991.160.020.490.00
Interest Expense0.750.000.000.000.000.00
Other Income/Expense9.28-5.100.050.01-0.015.33
Income
Income Before Tax-115.86-67.68-52.98-46.29-33.34-22.27
Income Tax Expense0.000.000.000.000.000.00
Net Income-115.86-67.68-52.98-46.29-33.34-22.27
Net Income - Continuous Operations-115.86-67.68-52.98-46.290.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.00
EBITDA-113.41-73.23-52.96-45.58-33.48-22.17
EBIT-115.12-74.66-54.14-46.31-33.83-22.27
Depreciation & Amortization1.711.431.180.730.35-0.10
Earnings Per Share
Basic EPS-2.00-2.00-2.00-2.00-1.00-4.00
Diluted EPS-2.00-2.00-2.00-2.00-1.00-4.00
Basic Shares Outstanding49.511.175.9425.7223.155.47
Diluted Shares Outstanding49.511.175.9425.7223.155.47